Success Metrics

Clinical Success Rate
85.1%

Based on 74 completed trials

Completion Rate
85%(74/87)
Active Trials
50(27%)
Results Posted
30%(22 trials)
Terminated
13(7%)

Phase Distribution

Ph phase_2
12
6%
Ph phase_3
4
2%
Ph phase_1
9
5%
Ph early_phase_1
6
3%
Ph phase_4
3
2%
Ph not_applicable
67
36%

Phase Distribution

15

Early Stage

12

Mid Stage

7

Late Stage

Phase Distribution101 total trials
Early Phase 1First-in-human
6(5.9%)
Phase 1Safety & dosage
9(8.9%)
Phase 2Efficacy & side effects
12(11.9%)
Phase 3Large-scale testing
4(4.0%)
Phase 4Post-market surveillance
3(3.0%)
N/ANon-phased studies
67(66.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.9%

74 of 95 finished

Non-Completion Rate

22.1%

21 ended early

Currently Active

50

trials recruiting

Total Trials

186

all time

Status Distribution
Active(58)
Completed(74)
Terminated(21)
Other(33)

Detailed Status

Completed74
Recruiting42
unknown32
Terminated13
Withdrawn8
Active, not recruiting8

Development Timeline

Analytics

Development Status

Total Trials
186
Active
50
Success Rate
85.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (5.9%)
Phase 19 (8.9%)
Phase 212 (11.9%)
Phase 34 (4.0%)
Phase 43 (3.0%)
N/A67 (66.3%)

Trials by Status

completed7440%
enrolling_by_invitation21%
not_yet_recruiting63%
unknown3217%
withdrawn84%
terminated137%
recruiting4223%
active_not_recruiting84%
suspended11%

Recent Activity

Clinical Trials (186)

Showing 20 of 186 trialsScroll for more
NCT07533799

The Swedish BioFINDER Sleep Study

Recruiting
NCT07226453Phase 2

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

Not Yet Recruiting
NCT07498270Not Applicable

Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep

Not Yet Recruiting
NCT07506239Not Applicable

Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma

Recruiting
NCT05887882Phase 1

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Recruiting
NCT07495332Not Applicable

Siemens Biomarker Multi-modality

Recruiting
NCT06492057Not Applicable

Electromyostimulation (EMS) of Astronauts in Spaceflight (Easymotion-2)

Enrolling By Invitation
NCT07110246Phase 2

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

Recruiting
NCT06504381Phase 1

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Recruiting
NCT04591106

Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

Completed
NCT06220396Not Applicable

CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study

Recruiting
NCT07447076Phase 2

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Not Yet Recruiting
NCT06470282Phase 1

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Recruiting
NCT07416825Not Applicable

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Completed
NCT07044596Not Applicable

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline

Recruiting
NCT07275814Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions

Recruiting
NCT07346170Not Applicable

Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases

Not Yet Recruiting
NCT07353229Phase 1

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Suspended
NCT03758521

Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency

Recruiting
NCT07275723Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
186